Garry E. Menzel

Companies

• Adaptimmune (United Kingdom)Board member Jun 1, 2023 to now¹
• Stoke Therapeutics, Inc.Board member Jan 27, 2021 to now²
• Black Diamond Therapeutics, Inc.Board member Jan 29, 2020 to now³
• TCR2 THERAPEUTICS INC.Board member Feb 13, 2019 to Jun 1, 2023⁴
• TCR2 THERAPEUTICS INC.Chief executive officer Feb 13, 2019 to Jun 1, 2023⁴
• TCR2 THERAPEUTICS INC.President Feb 13, 2019 to Jun 1, 2023⁴
• DaVitaSenior Vice President, Finance Sep 11, 2013 to Sep 11, 2013⁵
• Regulus Therapeutics Inc.Chief operating officer Oct 4, 2012 to Dec 13, 2012⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• AUAdaptimmune (United Kingdom) ADAPY275,703 shares⁷$6.5K at $0.02Jul 10, 2023
• TTTCR2 THERAPEUTICS INC.0 shares⁸Jun 1, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 10, 2023Sold 47,702 shares at $0.91 of Adaptimmune (United Kingdom)⁷
• Jun 1, 2023Granted 209,931 shares of Adaptimmune (United Kingdom)⁹
• Jun 1, 2023Returned to company 138,871 shares of TCR2 THERAPEUTICS INC.⁸
• Jun 1, 2023Granted 200,647 shares of Adaptimmune (United Kingdom)⁹
• Jun 1, 2023Returned to company 132,730 shares of TCR2 THERAPEUTICS INC.⁸
• Jun 1, 2023Granted 200,646 shares of Adaptimmune (United Kingdom)⁹
• Jun 1, 2023Returned to company 132,729 shares of TCR2 THERAPEUTICS INC.⁸
• Dec 13, 2022Sold 11,000 shares at $1.06 of TCR2 THERAPEUTICS INC.¹⁰
• Dec 12, 2022Sold 10,613 shares at $1.10 of TCR2 THERAPEUTICS INC.¹⁰
• Dec 9, 2022Sold 10,325 shares at $1.13 of TCR2 THERAPEUTICS INC.¹⁰
• Dec 8, 2022Sold 9,314 shares at $1.25 of TCR2 THERAPEUTICS INC.¹¹
• Dec 7, 2022Sold 9,111 shares at $1.28 of TCR2 THERAPEUTICS INC.¹¹
• Dec 6, 2022Sold 14,886 shares at $1.35 of TCR2 THERAPEUTICS INC.¹²
• Dec 5, 2022Sold 8,530 shares at $1.37 of TCR2 THERAPEUTICS INC.¹²
• Dec 2, 2022Sold 8,408 shares at $1.39 of TCR2 THERAPEUTICS INC.¹³
• Dec 1, 2022Exercised options 221,058 shares of TCR2 THERAPEUTICS INC.¹³
• Jul 5, 2022Gift 132,730 shares of TCR2 THERAPEUTICS INC.¹⁴
• Jul 5, 2022Gift 132,730 shares of TCR2 THERAPEUTICS INC.¹⁴
• Jul 5, 2022Gift 48,202 shares of TCR2 THERAPEUTICS INC.¹⁴
• Jul 5, 2022Gift 48,202 shares of TCR2 THERAPEUTICS INC.¹⁴
• Jul 5, 2022Gift 84,527 shares of TCR2 THERAPEUTICS INC.¹⁴
• Jul 5, 2022Gift 84,527 shares of TCR2 THERAPEUTICS INC.¹⁴
• Feb 28, 2022Granted 1,425 shares at $2.30 of TCR2 THERAPEUTICS INC.¹⁵
• Dec 9, 2021Exercised options 175,000 shares at $0.74 of TCR2 THERAPEUTICS INC.¹⁶
• Aug 31, 2021Granted 422 shares at $14.26 of TCR2 THERAPEUTICS INC.¹⁶